During the implementation, the customer’s medical leadership will determine the characteristics of the at-risk population that will be tested. Patients with existing conditions (e.g. diabetes, CKD, COPD, obesity, hypertension) who are at risk for structural heart changes but have no current abnormality should be tested with Vivio^®.